美股异动 | Aptose Biosciences(APTO.US)涨超64%，获奥本海默上调目标价至9美元
Aptose Biosciences Up Over 61%, On Track for Largest Percent Increase Since November 2013 -- Data Talk
What's Happening With APTO Stock And SNES Stock Today?
Aptose Biosciences Price Target Raised to $9.00/Share From $8.00 by Oppenheimer
Aptose Biosciences analyst ratings
Oppenheimer Maintains Outperform on Aptose Biosciences, Raises Price Target to $9
Aptose Biosciences Says CFO Gregory Chow to Resign
BRIEF-Aptose Biosciences Reports Qtrly Loss Per Share $0.17
12 Health Care Stocks Moving In Tuesday's After-Market Session
Aptose Biosciences shares are trading higher after the company reported Q4 earnings results.